Organization of cervical cancer screening with DNA–HPV testing impact on early–stage cancer detection: a population–based demonstration study in a Brazilian city
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 5, 100084
Abstract
No abstract availableKeywords
Funding Information
- Roche
- Universidade Estadual de Campinas (UNICAMP)
This publication has 23 references indexed in Scilit:
- Disparities in time trends of cervical cancer mortality rates in BrazilCancer Causes & Control, 2016
- Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening testGynecologic Oncology, 2015
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2014
- Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factorsEuropean Journal of Cancer, 2013
- Excessive pap smears due to opportunistic cervical cancer screening2008
- Mass screening programmes and trends in cervical cancer in Finland and the NetherlandsInternational Journal of Cancer, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992–98British Journal of Cancer, 2005
- Effective screening programmes for cervical cancer in low- and middle-income developing countries.2001
- Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statisticsBMJ, 1999